Skip to main content

Table 4 Analysis of OGTT from baseline to 12 weeks (ITT)

From: A clinical trial on anti-diabetic efficacy of submerged culture medium of Ceriporia lacerata mycelium

  

Placebo

CLM

p valuea

p valueb

 

Mean ± SD

Blood glucose

Baseline

148.0 ± 47.3

150.4 ± 58.6

0.848

 

after 12 weeks

138.5 ± 57.3

140.8 ± 51.6

0.862

 

Differencec

-9.5 ± 10.0

-9.6 ± 7.0

0.990

 

p valued

0.390

0.186

 

0.948

HbA1c

Baseline

5.7 ± 0.6

5.8 ± 0.5

0.519

 

after 12 weeks

5.8 ± 0.5

5.8 ± 0.5

0.987

 

Differencec

-0.1 ± 0.1

0.0 ± 0.0

0.274

 

p valued

0.891

0.126

 

0.324

Insulin

Baseline

6.6 ± 4.8

7.3 ± 5.5

0.599

 

after 12 weeks

7.2 ± 7.8

5.0 ± 4.9

0.149

 

Differencec

-0.6 ± 3.0

-2.3 ± 0.6

0.090

 

p valued

0.604

0.062

 

0.137

C-peptide

Baseline

2.2 ± 1.0

2.4 ± 1.4

0.542

 

after 12 weeks

2.2 ± 1.4

1.7 ± 0.7

0.048

 

Differencec

0.0 ± 0.4

-0.7 ± 0.7

0.014*

0.015*

p valued

0.729

0.002*

  
  1. aCompared between groups: p-value by independent t-test
  2. bCompared between groups: p-value by ANCOVA (adjustment with baseline and calorie)
  3. cDifference between the values of baseline and after 12 weeks
  4. dCompared within groups: p-value by paired t-test
  5. *p < 0.05